EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

EGFR and Its Ligands in Idiopathic Pulmonary Fibrosis: Predicting Clinical Outcomes and Molecular Endotyping Through In-Depth Analysis

Jong-Uk Lee iD, Seung-Lee Park iD, Min Kyung Kim iD, Eun-Jeong Seo iD, Hun-Gyu Hwang iD, Beomseok Son iD, Tae Rim Kim iD, Han-Oh Park iD, June Young Park iD, Hun Soo Chang iD, Choon-Sik Park iD

Journal of Korean Medical Science · 2026 · 41 (25)

DOI: 10.3346/jkms.2026.41.e185 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Korean Medical Science, 2026. Verfasst von Jong-Uk Lee und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interdisciplinary Program in Biomedical Science Major, Soonchunhyang University, Asan, Korea. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis, ErbB Receptors. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Idiopathic Pulmonary FibrosisErbB ReceptorsHumansTransforming Growth Factor alphaFemaleMaleAmphiregulinEpidermal Growth FactorBronchoalveolar Lavage FluidAgedLigandsProportional Hazards ModelsMiddle AgedPrognosisEnzyme-Linked Immunosorbent AssayHeparin-binding EGF-like Growth FactorCase-Control StudiesCluster AnalysisKaplan-Meier Estimate

Stichwörter der Autor:innen

ClusteringEGF ReceptorEGF Receptor LigandsIdiopathic Pulmonary Fibrosis

Substanzen

ErbB ReceptorsTransforming Growth Factor alphaAmphiregulinEpidermal Growth FactorLigandsEGFR protein, humanHeparin-binding EGF-like Growth FactorAREG protein, human

Autor:innen und Institutionen

  • Department of Interdisciplinary Program in Biomedical Science Major, Soonchunhyang University, Asan, Korea.
  • Division of Allergy and Respiratory Medicine, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.
  • siRNAgen Therapeutics, Cambridge, MA, USA.
  • Bioneer Corporation, Daejeon, Korea.
  • Cenos Therapeutics, San Carlos, CA, USA.
  • Department of Microbiology, College of Medicine, Soonchunhyang University, Cheonan, Korea. hschang@sch.ac.kr.

ORCID-Profile: Jong-Uk Lee, Seung-Lee Park, Min Kyung Kim, Eun-Jeong Seo, Hun-Gyu Hwang, Beomseok Son, Tae Rim Kim, Han-Oh Park, June Young Park, Hun Soo Chang, Choon-Sik Park

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Lee, J. U., Park, S. L., Kim, M. K., Seo, E. J., Hwang, H. G., Son, B., Kim, T. R., Park, H. O., Park, J. Y., Chang, H. S., & Park, C. S. (2026). EGFR and Its Ligands in Idiopathic Pulmonary Fibrosis: Predicting Clinical Outcomes and Molecular Endotyping Through In-Depth Analysis. Journal of Korean Medical Science, 41(25). https://doi.org/10.3346/jkms.2026.41.e185

Vancouver

Lee JU, Park SL, Kim MK, Seo EJ, Hwang HG, Son B, et al. EGFR and Its Ligands in Idiopathic Pulmonary Fibrosis: Predicting Clinical Outcomes and Molecular Endotyping Through In-Depth Analysis. Journal of Korean Medical Science. 2026;41(25). doi:10.3346/jkms.2026.41.e185

BibTeX
@article{Lee2026,
  author = {Lee, Jong-Uk and Park, Seung-Lee and Kim, Min Kyung and Seo, Eun-Jeong and Hwang, Hun-Gyu and Son, Beomseok and Kim, Tae Rim and Park, Han-Oh and Park, June Young and Chang, Hun Soo and Park, Choon-Sik},
  title = {EGFR and Its Ligands in Idiopathic Pulmonary Fibrosis: Predicting Clinical Outcomes and Molecular Endotyping Through In-Depth Analysis},
  journal = {Journal of Korean Medical Science},
  year = {2026},
  volume = {41},
  number = {25},
  doi = {10.3346/jkms.2026.41.e185}
}
Kostenlos starten →